| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |